"The microdosing strategy has some attractive benefits, including helping to mitigate side effects and being able to customize the dose to the minimum efficacious dose for individual patients," says Katie Sorensen , a nurse practitioner specializing in GLP-1 medications who was not involved in Burgess' treatment
During GLP-1 treatment , maintain regular contact with your healthcare team and report: Any new or worsening anxiety symptoms , including excessive worry, panic attacks, or physical anxiety symptoms Changes in mood , sleep patterns, or appetite beyond expected treatment effects Difficulty coping with side effects such as nausea, which may exacerbate anxiety Concerns about body image or eating behaviours as weight changes occur NICE guidance recommends holistic care for people with diabetes and obesity, recognising the importance of psychological wellbeing
Quick Answer: There is no established clinical evidence that tirzepatide directly causes patients to become quieter or experience personality changes
Muscle loss is a documented risk during GLP-1 (Wegovy and Zepbound) use that requires active clinical management, not just weight tracking
Cheng K, Andrikopoulos S, Gunton JE
doi:10.3389/fendo.2023.1121387 PMID: 37051199
